New Delhi: Leading researchers of Harvard Medical School have recently developed a new Artificial Intelligence (AI)-powered tool that harvests information in chest X-rays to predict long-term mortality.
Published in the journal JAMA Network Open, the tool can help identify patients most likely to benefit from screening and preventive medicine for heart disease, lung cancer and other conditions.
“This is a new way to extract prognostic information from everyday diagnostic tests,” said one of the researchers, Michael Lu, from Massachusetts General Hospital (MGH) of Harvard Medical School.
During a trial, the tool known as CXR-risk analysed more than 85,000 chest X-rays from 42,000 participants who took part in an earlier clinical trial. The goal was for CXR-risk to learn the features or combinations of features on a chest X-ray image that best predict health and mortality.
Next, Lu and colleagues tested CXR-risk using chest X-rays for 16,000 patients from two earlier clinical trials. They found that 53 per cent of people the neural network identified as “very high risk” died over 12 years, compared to fewer than four per cent of those that CXR-risk labeled as “very low risk.”
The study found that CXR-risk provided information that predicts long-term mortality, independent of radiologists’ readings of the x-rays and other factors, such as age and smoking status.
Researchers believe this new tool will be even more accurate when combined with other risk factors, such as genetics and smoking status.